ChiCTR1900027034 版本V1.1 版本创建时间2023/10/27 17:33:37 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR1900027034 

最近更新日期:

Date of Last Refreshed on:

2020-03-22 10:21:57 

注册时间:

Date of Registration:

2019-10-29 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

智能手机对结肠镜息肉检出率影响的前瞻性随机对照研究

Public title:

The effect of using during colonoscopy smart phones on the detection rate of polyps in colonoscopy: a prospective randomized controlled study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

智能手机对结肠镜息肉检出率影响的前瞻性随机对照研究

Scientific title:

The effect of using during colonoscopy smart phones on the detection rate of polyps in colonoscopy: a prospective randomized controlled study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

生立平 

研究负责人:

丁震 

Applicant:

Sheng Liping 

Study leader:

Ding Zhen 

申请注册联系人电话:

Applicant telephone:

+86 13343470549

研究负责人电话:

Study leader's
telephone:

+86 18602747746

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1107945275@qq.com

研究负责人电子邮件:

Study leader's E-mail:

docd720@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

湖北省武汉市江汉区解放大道1277号

研究负责人通讯地址:

武汉市江汉区解放大道1277号

Applicant address:

1277 Jiefang Avenue, Jianghan District, Wuhan, Hubei, China

Study leader's address:

1277 Jiefang Avenue, Jianghan District, Wuhan, Hubei, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

武汉协和医院

Applicant's institution:

Wuhan Union Hospital

研究负责人所在单位:

武汉协和医院

Affiliation of the Leader:

Wuhan Union Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2018 S479

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

华中科技大学同济医学院医学伦理委员会

Name of the ethic committee:

The Ethics Committee of the Tongji Medical College, Huazhong University of Science and Technology

伦理委员会批准日期:

Date of approved by ethic committee:

2018-11-07 00:00:00

伦理委员会联系人:

陈汇

Contact Name of the ethic committee:

Chen Hui

伦理委员会联系地址:

湖北省武汉市航空路13号

Contact Address of the ethic committee:

13 Hangkong Road, Wuhan, Hubei, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

武汉协和医院

Primary sponsor:

Wuhan Union Hospital

研究实施负责(组长)单位地址:

武汉市江汉区解放大道1277号

Primary sponsor's address:

1277 Jiefang Avenue, Jianghan District, Wuhan, Hubei, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖北

市(区县):

武汉

Country:

China

Province:

Hubei

City:

Wuhan

单位(医院):

武汉协和医院

具体地址:

江汉区解放大道1277号

Institution
hospital:

Wuhan Union Hospital

Address:

1277 Jiefang Avenue, Jianghan District

经费或物资来源:

Source(s) of funding:

no

研究疾病:

结肠镜检查  

Target disease:

colonoscopy

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

主要研究目的:对比智能手机的使用与否对于结肠镜息肉检出率的影响。 次要研究目的:比较智能手机的使用是否能提高被检者对电子结肠镜的耐受程度;比较智能手机的使用是否能减轻被检者结肠镜检查后的不适症状;比较智能手机的使用是否能够缩短结肠镜的完成时间。  

Objectives of Study:

Main objective is to study the effects of using smart phones during colonoscopy on the detection rate of polyps. Secondary research objective is to investigate whether smart phones can improve the tolerance of patients, reduce the discomfort associated with colonoscopy, and shorten the total time of the procedure.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.年龄16~60岁;
2.日常经常使用智能手机;
3.同意参加本研究者,并签署知情同意书。

Inclusion criteria

1) The age was 16-60 years old.
2) Participants often use smart phones.
3) Participants agree to participate in the study and sign the informed consent.

排除标准:

1.有内镜操作禁忌症;
2.肠道狭窄或肿瘤梗阻;
3.肠造瘘;
4.吞咽困难;
5.合并吞咽反射或精神疾病(抑郁、焦虑、疑病症、癔症等患者);
6.严重胃轻瘫或胃出口梗阻;
7.急性肠梗阻;
8.肠穿孔或急性腹膜炎;
9.严重慢性肾衰竭(肌酐清除率<30 ml/min);
10.严重心功能不全(NYHA分级≥Ⅲ级);
11.血压控制不理想的高血压病患者(收缩压≥170mmHg,舒张压≥100mmHg);
12.急性细菌性痢疾、急性重度结肠炎及急性重度溃疡性结肠炎;
13.脱水或电解质紊乱;
14.妊娠或哺乳期妇女;
15.消化道活动性出血;
16.中重度通气功能障碍患者;
17.凝血功能障碍。

Exclusion criteria:

1) Contraindications of endoscopic operation;
2) Intestinal stenosis or tumor obstruction;
3) Enterostomy;
4) Dysphagia;
5) Patients with swallowing reflex or mental illness (depression, anxiety, hypochondriasis, hysteria, etc.);
6) Severe gastroparesis or outlet obstruction;
7) Acute intestinal obstruction;
8) Intestinal perforation or acute peritonitis;
9) Severe chronic renal failure (creatinine clearance < 30 ml / min);
10) Severe cardiac insufficiency (NYHA grade >= grade III);
11) Hypertension patients with poor blood pressure control (systolic blood pressure >= 170mmhg, diastolic blood pressure >= 100mmhg);
12) Acute bacterial dysentery, acute severe colitis and acute severe ulcerative colitis;
13) Dehydration or electrolyte disorder;
14) Pregnant or lactating women;
15) Active hemorrhage of digestive tract;
16) Patients with moderate or severe ventilatory dysfunction;
17) Coagulation dysfunction.

研究实施时间:

Study execute time:

From 2019-10-30 00:00:00 To 2020-02-29 00:00:00  

征募观察对象时间:

Recruiting time:

From 2019-10-30 00:00:00 To 2020-02-29 00:00:00

干预措施:

Interventions:

组别:

A

样本量:

180

Group:

A

Sample size:

干预措施:

干预措施代码:

1

Intervention:

no

Intervention code:

组别:

B

样本量:

180

Group:

B

Sample size:

干预措施:

使用手机

干预措施代码:

2

Intervention:

use smart phones

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

湖北 

市(区县):

武汉 

Country:

China

Province:

Hubei

City:

Wuhan

单位(医院):

武汉协和医院 

单位级别:

三甲医院 

Institution
hospital:

Wuhan Union Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

息肉检出率

指标类型:

主要指标

Outcome:

detection rate of polyps

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

腹痛

指标类型:

次要指标

Outcome:

Abdominal pain

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

腹胀

指标类型:

次要指标

Outcome:

Abdominal distention

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

重复检查的意愿

指标类型:

次要指标

Outcome:

willing to repeat colonoscopy with same method

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

智能手机的使用对参与者是否有帮助

指标类型:

次要指标

Outcome:

whether smart phones is beneficial for participants

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

满意度

指标类型:

次要指标

Outcome:

satisfaction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

并发症

指标类型:

次要指标

Outcome:

Complication

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

检出其他疾病

指标类型:

次要指标

Outcome:

Detection of other diseases

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 16 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

使用随机数随机分组

Randomization Procedure (please state who generates the random number sequence and by what method):

Participants are randomly assigned by random numbers.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

统计学家进行盲态核查及统计分析。

Blinding:

Blind method for statisticians.

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

暂未确定

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not yet

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2019-10-29 18:40:21